Sinovac, Pfizer/BioNtech Covid-19 vaccines prove highly effective in Uruguay



Uruguay on Tuesday released real-world data on the impact of Sinovac Biotech's Covid-19 vaccine among its population that showed it was over 90 percent effective in preventing intensive care admissions and deaths.

The shot reduced deaths by 95 percent and intensive care admissions by 92 percent, and also showed 61 percent efficacy in cutting coronavirus infections, the government said...

All Access Plan


per month
Unlimited access to our articles
Comment on all our stories
Gift articles to your friends
Subscribe Now
You can cancel anytime.
Secure and Encrypted
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In